nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
1 |
Biology
|
Collin, Mattias |
|
|
9 |
7 |
p. 338-340 |
artikel |
2 |
Business
|
Clough, Joanne |
|
|
9 |
7 |
p. 341 |
artikel |
3 |
Chemistry
|
Barlocco, Daniela |
|
|
9 |
7 |
p. 337-338 |
artikel |
4 |
Erratum
|
|
|
|
9 |
7 |
p. 336 |
artikel |
5 |
Getting more mileage out of a tankful of new molecular entities?
|
Cavalla, David |
|
|
9 |
7 |
p. 304-305 |
artikel |
6 |
Improving drug discovery output – starting with the early discovery enterprise
|
Sofia, Michael J |
|
|
9 |
7 |
p. 293-295 |
artikel |
7 |
Model organisms in drug discovery
|
Tissenbaum, Heidi A. |
|
|
9 |
7 |
p. 309 |
artikel |
8 |
Multidimensional separation and hyphenated techniques in pharmaceutical research: practical considerations
|
Cheng, Xueheng |
|
|
9 |
7 |
p. 305-306 |
artikel |
9 |
New rotavirus vaccine could be licensed this year
|
Nicholls, Henry |
|
|
9 |
7 |
p. 298 |
artikel |
10 |
People
|
Clough, Joanne |
|
|
9 |
7 |
p. 341-342 |
artikel |
11 |
Revival of the regulatory Tcell: new targets for drug development
|
Sutmuller, Roger P.M |
|
|
9 |
7 |
p. 310-316 |
artikel |
12 |
RNAi and siRNA in target validation
|
Jain, Kewal K |
|
|
9 |
7 |
p. 307-309 |
artikel |
13 |
Strategies for dealing with metabolite elucidation in drug discovery and development
|
Nassar, Alaa-Eldin F |
|
|
9 |
7 |
p. 317-327 |
artikel |
14 |
Strategies for using in vitro screens in drug metabolism
|
Plant, Nick |
|
|
9 |
7 |
p. 328-336 |
artikel |
15 |
Stuart Schreiber: biology from a chemist’s perspective
|
Schreiber, Stuart L |
|
|
9 |
7 |
p. 299-303 |
artikel |
16 |
The complex issue of immune evasion
|
Nicholls, Henry |
|
|
9 |
7 |
p. 296 |
artikel |
17 |
Therapeutic potential of a communication breakdown
|
Perks, Bea |
|
|
9 |
7 |
p. 297 |
artikel |